Tianying Pharmaceuticals intends to set up a medical clinic management department

10 years of nine losses of the Tianmen pharmaceutical industry, this layout of rural medical care, whether to panic, or to renew the face, make a comeback? Whether the "first stock of Chinese medicine" in the past can break the woes of consecutive years of losses is worth looking forward to in the future.
June 11, Tianmei Pharmaceuticals announced that, in order to effectively promote the business development of rural medical clinics, strengthen the unified management of rural medical clinics and Sanshentai outpatient clinics, after its research decision, the proposed establishment of a medical clinic management department. Tianying Pharmaceuticals said that after the establishment of the medical clinic management department, as soon as possible with more than 100 rural clinics signed a formal intention to cooperate.
Tianming Pharmaceuticals originated in 1958, "Tianmangshan People's Commune State Pharmaceutical Farm", listed on the Shanghai Stock Exchange in 1993, becoming the country's first Chinese pharmaceutical preparations listed enterprises. Tianding Pharmaceuticals is mainly engaged in pharmaceutical preparations, outpatient clinics, drug circulation and other business. Sanshentai outpatient clinic for tianmei pharmaceutical industry's outpatient business operators, opened a Chinese medicine medicine, Chinese medicine obstetrics and gynecology, Western medicine, Chinese medicine acupuncture, Chinese and Western medicine combined with specialty.
that in September 2017, Tianmei Pharmaceuticals paid 21.4 million yuan for a 51% stake in Sanshentai Clinic. In fiscal 2018, Sanshentai Outpatient Department achieved revenue of RMB39.6103 million and net profit of RMB5.5495 million. Tianyi Pharmaceuticals said in the announcement that it would not rule out the acquisition of the remaining 49% stake in Sanshentai Outpatient Department and the acquisition of other high-quality Chinese medicine outpatient department assets of Hangzhou Haoyu.
stage, Tianmen Pharmaceutical Lin'an Pharmaceutical Center plant is facing the overall relocation, its production and operation has caused a greater impact. To this end, Tianding Pharmaceuticals, on the one hand, through overtime production, increase product inventory to meet the needs of the sale of products during the shutdown period, on the other hand, through participation in the judicial auction of land and plant assets, the use of the existing plant obtained by the auction for the production line GMP transformation, in the shortest possible time to build and put into production, resume production.
years, the state's policy support for medical services in rural clinics has been increasing. Now, in May of this year, the National Health and Safety Commission and other five departments jointly issued the Opinions on The Pilot for the Development of Clinics, proposing innovative reform measures to encourage qualified physicians to open specialist or general clinics full-time or part-time. In addition, by the end of 2018, 897 million people had participated in basic medical insurance for urban and rural residents in China, and 130 million people had been insured in new rural cooperative medical insurance. Based on the above policy dividend and market space can be predicted, China's urban and rural and rural rural medical clinics have a very huge market prospects.
pharmaceutical industry said that the relocation as an opportunity to adjust the layout of the production line. Its plan to rural medical clinics as an entry point, and gradually form a complete large health industry chain, and then increase the new profit growth point, fundamentally enhance its main size and profitability. The establishment of the Medical Clinic Management Department is also a plan to open up the intermediate link of Chinese medicine, to develop towards the direction of the whole industry platform of Chinese medicine.
understood that Tianming Pharmaceuticals to jump out of the original business model, in addition to the layout of rural medical clinics, but also accelerate the promotion of Yinchuan Tianmingshan Hot Springs health care projects and other matters. Its holding subsidiary Tianmou Bio, using the characteristics of "Fairy Grass Town" and the geographical advantages of Tianmoushan National Nature Reserve, integrates the cultivation, tourism, health and leisure of tin-skin pythons into one, builds a healthy ecological park, and vigorously develops the "tourism and health" industry.
from Tianding Pharmaceuticals' net profit deduction in the past ten years, except for the 2014 net profit of 2.52 million yuan, the remaining nine years are losses. Among them, losses in 2009 and 2012 amounted to 54.98 million yuan and 90.44 million yuan, respectively. Even though Tianming Pharmaceuticals' operating income in 2018 was up 103.23 percent from the previous year, its net profit from deductions was still RMB25,828.3 million. After such a large adjustment, the former "first stock of Chinese medicine" can make a comeback, it will take time to verify. (Xu Tao Yio Medical)